Evaxion presents preclinical data for acute myeloid leukemia vaccine

June 11, 2026 2:00 AM

Evaxion A/S (NASDAQ: EVAX) announced preclinical data for EVX-04, a therapeutic vaccine candidate for acute myeloid leukemia. The company will ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found